Up to 400 jobs are to go at chilled foods manufacturer Greencore’s Evercreech factory in Somerset, after the company announced the final closure date for the site.
Interest in food and drink mergers and acquisitions (M&A) should rise in 2014, according to a report shortly to be published by London-based Oghma Partners.
Unite the union has demanded “copper bottomed guarantees” about the security of workers’ employment and their terms and conditions, after GlaxoSmithKline (GSK) sold its Lucozade and Ribena brands to Japanese company Suntory for £1.35bn.
Soft drinks manufacturer AG Barr is reportedly considering making a £1bn bid for the Lucozade and Ribena businesses that GlaxoSmithKline (GSK) has put up for sale.
Irn Bru maker AG Barr is remaining tight-lipped about press reports that it is preparing a £1bn bid for GlaxoSmithKline’s (GSK’s) iconic drink brands Ribena and Lucozade, in the wake of its failed merger bid with Britvic.
GlaxoSmithKline (GSK) has announced it is to sell its soft drink brands Lucozade and Ribena, in a bid to improve its strategic focus and enhance its growth profile.
Glaxo SmithKline (GSK), the makers of iconic brands Ribena and Lucozade, are to invest £18M in a new bottling facility at its Coleford, Gloucestershire, which will create 20 new jobs.
Is open innovation just a fancy term to describe what manufacturers have been doing for years, or is it genuinely changing how (and how fast) new products get to market?
GlaxoSmithKline (GSK) is actively seeking partnerships with entrepreneurs, academics, suppliers or other third parties to develop brands like Ribena,...